Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
종목 코드 CYRX
회사 이름Cryoport Inc
상장일Jul 24, 2015
CEOMr. Jerrell Wilson (Jerry) Shelton
직원 수1090
유형Ordinary Share
회계 연도 종료Jul 24
주소112 Westwood Place, Suite 350
도시BRENTWOOD
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호37027
전화19492321900
웹사이트https://www.cryoport.com/
종목 코드 CYRX
상장일Jul 24, 2015
CEOMr. Jerrell Wilson (Jerry) Shelton
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음